Fava M

Department of Psychiatry, Massachusetts General Hospital, Boston, USA.

5 papers · ORCID

ArticleKetamine

Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

Gould TD, Mathew SJ, Fava M +1

Europe PMC2026
ArticlePsilocybin

Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.

Guidetti C, Fava M, Papakostas GI

Europe PMC2026
ArticleLSD

Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial.

Robison R, Barrow R, Conant C +9

Europe PMC2025
ArticlePsilocybin

What should constitute a control condition in psychedelic drug trials?

Colloca L, Fava M

Europe PMC2024
ArticlePsilocybin

A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.

Pilozzi A, Foster S, Mischoulon D +2

Europe PMC2023